Filing Details
- Accession Number:
- 0001415889-23-010459
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-30 16:21:11
- Reporting Period:
- 2023-06-28
- Accepted Time:
- 2023-06-30 16:21:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468308 | Robert Andrade | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-06-28 | 10,000 | $8.99 | 139,721 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2023-06-29 | 7,500 | $8.97 | 132,221 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2023-06-30 | 7,500 | $8.82 | 124,721 | No | 4 | S | Direct | |
| Common Shares | Acquisiton | 2023-06-30 | 25,000 | $2.45 | 149,721 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Options | Common Shares | Disposition | 2023-06-30 | 25,000 | $2.45 | 25,000 | $2.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 605,000 | 2016-07-05 | 2026-07-05 | No | 4 | M | Direct |
Footnotes
- Represents shares sold pursuant to a 10b5-1 plan on June 28, 2023.
- Represents shares sold pursuant to a 10b5-1 plan on June 29, 2023.
- Represents shares sold pursuant to a 10b5-1 plan on June 30, 2023.
- Shares aquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026.
- Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026.
Billionaire Hedge Funds
